Evidence map›Paper›PMID 37240073›Full record

ArticleInternational journal of molecular sciences2023

Bibiana Chavarro-Portillo, Carlos Y Soto, Martha Inírida Guerrero

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Bibiana Chavarro-PortilloHospital Universitario Centro Dermatológico Federico Lleras Acosta, Avenida 1ra # 13A-61, Bogotá 111511, Colombia.ORCID 0000-0001-7186-2028
Carlos Y SotoChemistry Department, Faculty of Sciences, Universidad Nacional de Colombia, Ciudad Universitaria, Carrera 30 N° 45-03, Bogotá 111321, Colombia.ORCID 0000-0001-8694-7489
Martha Inírida GuerreroHospital Universitario Centro Dermatológico Federico Lleras Acosta, Avenida 1ra # 13A-61, Bogotá 111511, Colombia.ORCID 0000-0003-1612-115X
Universidad Nacional de Colombia · COCentro Dermatológico Federico Lleras Acosta · CO

Funding

MinCiencias No. 212084368694, CT 847-2019Ministerio de Ciencia Tecnología e Innovación, Colombia 727-2015
6 · The paper itself

Abstract

Peripheral nerves and Schwann cells (SCs) are privileged and protected sites for initial colonization, survival, and spread of leprosy bacillus.

Indexed as

LeprosyMycobacterium lepraeAntibodiesAntigens, BacterialDrug Therapy, CombinationGlycolipidsHumansLeprostatic AgentsSchwann CellsAntibodiesAntigens, BacterialGlycolipidsLeprostatic Agentsinfectionintracellular pathogenleprosy recurrenceMycobacterium leprae (M. leprae)phenolic glycolipid-I (PGL-I)Schwann cells (SCs)

Identifiers

PMID37240073
PMCPMC10218259
OpenAlexW4378515809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.